Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
Jeremy S. Abramson, Matthew Hellmann, Jeffrey A. Barnes, Peter Hammerman, Christiana Toomey, Tak Takvorian, Alona Muzikansky, Ephraim P. HochbergVolume:
116
Year:
2010
Language:
english
Pages:
8
DOI:
10.1002/cncr.25278
File:
PDF, 174 KB
english, 2010